Fast Five Quiz: Relapsing-Remitting Multiple Sclerosis Management

Christopher Luzzio, MD; Kerstin Hellwig, MD


June 30, 2022

Routes by which drugs for RRMS are administered are:

  • Oral: fingolimod, siponimod, cladribine, diroximel fumarate, ozanimod, teriflunomide, dimethyl fumarate, monomethyl fumarate

  • Intravenous: ocrelizumab, natalizumab, mitoxantrone

  • Intramuscular: Interferon beta-1a

  • Subcutaneous: Interferon beta-1a, Interferon beta-1b, glatiramer acetate

Learn more about the diagnosis and management strategies of MS.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.